These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7755388)

  • 1. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
    Toi M; Taniguchi T; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
    Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of breast cancer with lung and bone metastasis treated successfully by oral combination chemotherapy of 5'-deoxy-5-fluorouridine and cyclophosphamide].
    Ishii K; Tsugawa K; Nakamura M; Ohnishi I; Miwa K
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2133-6. PubMed ID: 14712778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
    Kobayashi J; Kubota K; Ishikawa H; Asaumi S; Iwanami K; Matsumoto H; Kawashima K; Yokoe T; Iino Y; Morishita Y
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2513-6. PubMed ID: 7944501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Noguchi S; Yamamoto H; Inaii H; Koyama H
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A patient with recurrent breast cancer whose liver metastasis regressed following combined use of weekly docetaxel and MPA.5'-DFUR].
    Nakagomi H; Miyauchi Y; Okuda J; Muto S; Akaike H; Takahashi M; Mitui T; Ashizawa I; Chiba S; Nakazawa M; Imamura K
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1431-5. PubMed ID: 11681252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
    Kihara M; Kontani K; Yamauchi A; Yokomise H
    Gan To Kagaku Ryoho; 2005 May; 32(5):683-6. PubMed ID: 15918573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA].
    Otsuka T; Terashima Y; Tashiro S
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):313-6. PubMed ID: 11865641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer].
    Matsuoka T; Nomizu T; Yabuta T; Katagata N; Watanabe F; Yamaki Y; Tsuchiya A; Takenoshita S
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):1051-5. PubMed ID: 10925694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
    Hoshino K; Nakamura M; Ikeda H; Koyama T; Morishita Y
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):983-7. PubMed ID: 10396328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
    Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
    Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin].
    Sawada M; Ono Y; Fukushima M
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):259-62. PubMed ID: 12610876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of postoperative recurrent breast cancer with multiple lung metastases that completely responded to combination therapy of docetaxel (TXT) and medroxyprogesterone acetate (MPA)].
    Mio H
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):985-8. PubMed ID: 12894715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
    Yoshinaka K; Yagi M; Ohtagaki S; Toi M; Toge T
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):115-8. PubMed ID: 1824814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
    Kim R; Osaki A; Tanabe K; Kojima J; Toge T
    Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report].
    Tanaka R; Fukushima H; Sato K; Matsuda M; Hanaoka T; Goya T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1647-50. PubMed ID: 10553425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
    Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.